Integer Holdings (ITGR) Financial Analysis & Valuation | Quarter Chart
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, perip... more
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United State... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $4.29B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Payman Khales |
| IPO Date | 2000-09-29 | CAGR | 12.87% |
| Employees | 11,000 | Website | www.integer.net |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 1.76% | Total Yield | 1.76% |
ITGR chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $4.64B | P/E | 19.89 | Forward P/E | 18.4 | PEG | -1.03 |
| P/S | 3.1 | P/B | 3.34 | P/CF | 27.82 | P/FCF | 36.04 |
| Sales | $1.84B | Sales 1Y | 2.86% | Sales 3Y | 23.2% | Sales 5Y | 66.26% |
| EPS | $6.35 | EPS 1Y | 61.23% | EPS 3Y | 75.12% | EPS 5Y | 24.91% |
| Sales QoQ | 5.58% | EPS QoQ | 43.75% | Sales QoQ Avg | -0.37% | EPS QoQ Avg | 2.4% |
| Gross Margin | 23.73% | Operating Margin | 9.47% | Profit Margin | 6.97% | ROCE | 5.44% |
| ROA | 4% | ROE | 7% | Altman Z Score | 2.81 | Piotroski Score | 7 |
| Current Ratio | 3.73 | Quick Ratio | 2.41 | Cash Ratio | 0.1 | Op. CF Ratio | 0.28 |
| Debt/Equity | 0.79 | Debt/Assets | 0.4 | Lt Debt/Equity | 0.79 | Lt Debt/Cap. | 0.44 |
| Intrst Cov. | 4.53 | Inventory Turnover | 4.87 | Asset Turnover | 0.54 | Receivables Turnover | 5.44 |
| Enterprise Value | $4.64B | P/E Ratio | 19.89 |
| Forward P/E | 18.4 | PEG Ratio | -1.03 |
| P/S Ratio | 3.1 | P/B Ratio | 3.34 |
| P/CF Ratio | 27.82 | P/FCF Ratio | 36.04 |
| EPS | $6.35 | EPS Growth 1Y | 61.23% |
| EPS Growth 3Y | 75.12% | EPS Growth 5Y | 24.91% |
| Revenue Growth 1Y | 2.86% | Gross Margin | 23.73% |
| Operating Margin | 9.47% | Profit Margin | 6.97% |
| ROE | 7% | ROA | 4% |
| ROCE | 5.44% | Current Ratio | 3.73 |
| Quick Ratio | 2.41 | Cash Ratio | 0.1 |
| Debt/Equity | 0.79 | Interest Coverage | 4.53 |
| Altman Z Score | 2.81 | Piotroski Score | 7 |
Integer Holdings (ITGR) valuation & financials
Integer Holdings (ITGR) has a market capitalization of $4.29B and trades at a price-to-earnings ratio of 19.9. It operates in the Healthcare sector (Medical - Devices).
Integer Holdings's revenue grew +2.9% over the last year.
Integer Holdings's next earnings report is scheduled for October 22, 2026 (provider scheduled date); analysts estimate EPS of $1.68. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)